New Pathophysiological Pathways Involved in Iron Metabolism Disorder in Heart Failure: The IRON-PATH II Investigator Initiated Study
Latest Information Update: 24 Sep 2021
At a glance
- Drugs Ferric carboxymaltose (Primary)
- Indications Iron metabolism disorders
- Focus Pharmacodynamics
- Acronyms IRON-PATH II
- 06 Sep 2021 Status changed from not yet recruiting to recruiting.
- 19 Aug 2021 New trial record